GE HealthCare announced the launch of Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. As a global leader in ultrasound-guided solutions in urology, this AI-based software feature is designed to support clinicians in prostate imaging, biopsies and guiding treatment. This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume.

The added functionality with PVA can determine calculations and measurements of the organ with an automated, one-click process. The prostate volume is an essential measurement in the imaging workflow as it is helpful in identifying and planning treatment for several prostate diseases, including prostate cancer where these calculations are critical in determining prostate-specific antigen density (PSAD), a value used to detect and manage the disease. Prostate cancer impacts millions of men around the world and is one of the leading causes of cancer-related deaths.2 In 2020, prostate cancer accounted for 14.1% of all cancer cases in men and 6.8% of all cancer-related deaths in men.2 The disease burden of prostate cancer continues to increase, creating a need for effective prevention, management and treatment approaches.

PVA will be available on the bkActiv, bk3000/5000 and bkSpecto. The addition of the PVA AI software feature supports this scalable portfolio of products to assist clinicians in managing treatment with greater confidence. The robust surgical visualization and guidance portfolio includes the next-generation bkActiv--which employs advanced algorithms to automatically optimize image clarity, providing enhanced detail image quality--as well as bkSpecto and bk3000/5000 for high-quality ultrasound guidance for urology procedures.

PVA on the bkActiv, Bk3000/5000 and bKSpecto are available in key countries around the globe. GE HealthCare will debut the new AI technology at the European Association of Urology Congress in Paris on April 5 to April 8 and American Urological Association Annual Meeting in San Antonio on May 3 to May 6.